Noritaka Takatsu Selected Research

Adalimumab (Humira)

12/2021

Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noritaka Takatsu Research Topics

Disease

7	Crohn Disease (Crohn's Disease) 03/2022 - 01/2010
4	Ulcerative Colitis 12/2021 - 01/2014
2	Pathologic Constriction (Stenosis) 03/2022 - 11/2012
2	Ulcer 01/2015 - 01/2010
2	Neoplasms (Cancer) 07/2013 - 12/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2010 - 01/2009
1	Disease Progression 07/2019
1	Syncope (Fainting) 07/2018
1	Dizziness (Lightheadedness) 07/2018
1	Obesity 08/2016
1	Pain (Aches) 04/2011
1	Diplopia (Double Vision) 12/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009

Drug/Important Bio-Agent (IBA)

3	Infliximab (Remicade)FDA Link 04/2018 - 11/2012
2	AntibodiesIBA 03/2022 - 04/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 02/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2018 - 08/2016
2	Azathioprine (Imuran)FDA LinkGeneric 01/2010 - 07/2009
1	Anti-Idiotypic AntibodiesIBA 03/2022
1	Adalimumab (Humira)FDA Link 12/2021
1	Immunologic Factors (Immunomodulators)IBA 12/2021
1	IntegrinsIBA 01/2020
1	vedolizumabIBA 01/2020
1	Capsules (Microcapsules)IBA 01/2018
1	Cytochrome P-450 CYP3AIBA 01/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2014
1	Tumor Biomarkers (Tumor Markers)IBA 07/2013
1	Carbon DioxideIBA 04/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2010
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 07/2009
1	AclarubicinIBA 01/2009
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2009

Therapy/Procedure

8	Therapeutics 03/2022 - 01/2009
1	Enteral Nutrition (Feeding, Tube) 02/2020
1	Aftercare (After-Treatment) 01/2010